NMT1 and cancer: For combination strategies, exploring the synergistic effects of NMT1 inhibitors with oncolytic viruses or CAR-T-cell therapy could be promising, with the aim of further activating antitumor immune responses and broadening the treatment landscape for cancer [52, 53].